The fourth General Session featured data from trials on breast-conserving therapy and local recurrence, short-term recurrence rates in patients who pause endocrine therapy to pursue pregnancy, and more.

The fifth General Session included data from two preclinical studies suggesting new approaches to both treating and identifying brain metastases in triple negative and inflammatory breast cancer.

Adetunji T. Toriola, MD, PhD, MPH, spoke Friday about his work in identifying molecular determinants of mammographic density and breast cancer risk in premenopausal women.

Norman Wolmark, MD, FACS, FRCSC, received the Brinker Award for Scientific Distinction in Clinical Research on Friday for his pioneering work in breast conservation, clinical trials, and landmark genomic testing.